Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD)
2011

CD40 and CD45 in Microglial Activation and HIV Associated Dementia

publication Evidence: moderate

Author Information

Author(s): Jon Salemi, Demian F. Obregon, Anthony Cobb, Spenser Reed, Edin Sadic, Jingji Jin, Francisco Fernandez, Jun Tan, Brian Giunta

Primary Institution: University of South Florida

Hypothesis

CD40 and CD45 modulation of microglial activation states may represent critical therapeutic targets for HIV associated dementia.

Conclusion

The study suggests that CD45 acts as a regulatory 'off switch' for harmful microglial activation in HIV associated dementia.

Supporting Evidence

  • Microglial dysfunction is linked to neurodegenerative disorders like HIV associated dementia.
  • CD40 promotes a harmful microglial state, while CD45 can help switch it off.
  • Chronic inflammation in the brain is exacerbated by HIV infection.
  • Microglia play a significant role in the pathogenesis of both HIV associated dementia and Alzheimer's disease.

Takeaway

Microglia, the brain's immune cells, can become harmful in HIV associated dementia, but a protein called CD45 can help turn off this harmful state.

Digital Object Identifier (DOI)

10.1186/1750-1326-6-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication